Drug intelligence / Profile preview

HUASHANG NO.1

Development stage: Preclinical
Lead developer: Science and Technology Commission of Shanghai
Administration: Topical

Overview

HUASHANG NO.1 is a traditional Chinese medicine hot compress prescription developed by the Science and Technology Commission of Shanghai and Huadong Hospital. It is currently undergoing clinical research for its therapeutic application in Cold BI, a condition often associated with traditional Chinese medicine diagnoses. The prescription is applied topically as a hot compress.

Other names: HUASHANG NO.1 hot compress prescription华伤Ⅰ号熨疗方

Beyond the preview

Go deeper on HUASHANG NO.1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HUASHANG NO.1.

Explore the full profile